martes, 1 de julio de 2025

FDA requires expanded labeling about weight loss risk in patients younger than 6 years taking extended-release stimulants for ADHD

https://www.fda.gov/drugs/drug-safety-and-availability/fda-requires-expanded-labeling-about-weight-loss-risk-patients-younger-6-years-taking-extended

No hay comentarios: